"TORONTO, Nov. 17, 2011 /CNW/ - Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced that the Company is developing a blood test to be used as a diagnostic tool for amyotrophic lateral sclerosis (ALS)."
http://www.newswire.ca/en/story/879...-its-als-disease-management-product-portfolio
http://www.newswire.ca/en/story/879...-its-als-disease-management-product-portfolio
